The Influence of Adalimumab and Cyclosporine A on the Expression Profile of the Genes Related to TGF<i>β</i> Signaling Pathways in Keratinocyte Cells Treated with Lipopolysaccharide A

<div>Results of cytotoxicity assay ((a) HaCaT with LPS, (b) HaCaT with adalimumab, (c) HaCaT with cyclosporine A, and (d) HaCaT with LPS and adalimumab or cyclosporine A).</div>

Mediators of Inflammation

fig1

Figure 1

Figure 1: The Influence of Adalimumab and Cyclosporine A on the Expression Profile of the Genes Related to TGF<i>β</i> Signaling Pathways in Keratinocyte Cells Treated with Lipopolysaccharide A 

Figure 1 | The Influence of Adalimumab and Cyclosporine A on the Expression Profile of the Genes Related to TGFβ Signaling Pathways in Keratinocyte Cells Treated with Lipopolysaccharide A 